Comparison of chemotherapy regimens for concurrent chemoradiotherapy in unresectable stage III non-small cell lung cancer

International Journal of Clinical Oncology ◽

10.1007/s10147-009-0907-2 ◽

2009 ◽

Vol 14 (6) ◽

pp. 507-512 ◽

Author(s):

Hideyuki Harada ◽

Nobuyuki Yamamoto ◽

Toshiaki Takahashi ◽

Masahiro Endo ◽

Haruyasu Murakami ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Concurrent Chemoradiotherapy ◽

Stage Iii ◽

Small Cell Lung ◽

Unresectable Stage

Download Full-text

Durvalumab After Concurrent Chemoradiotherapy in Elderly Patients with Unresectable Stage III Non-Small-Cell Lung Cancer (PACIFIC)

Clinical Lung Cancer ◽

10.1016/j.cllc.2021.05.009 ◽

2021 ◽

Author(s):

Mark A. Socinski ◽

Mustafa Özgüroğlu ◽

Augusto Villegas ◽

Davey Daniel ◽

David Vicente ◽

...

Keyword(s):

Lung Cancer ◽

Elderly Patients ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Concurrent Chemoradiotherapy ◽

Stage Iii ◽

Small Cell Lung ◽

Unresectable Stage

Download Full-text

Durvalumab after concurrent chemoradiotherapy in a patient with chemotherapy-resistant unresectable stage III non-small cell lung cancer: a case report

Annals of Palliative Medicine ◽

10.21037/apm-20-1118 ◽

2020 ◽

Vol 9 (4) ◽

pp. 2375-2380 ◽

Author(s):

Tao Zhang ◽

Yuqi Wu ◽

Shan Zheng ◽

Guowei Cheng ◽

Xiangling He ◽

...

Keyword(s):

Lung Cancer ◽

Case Report ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Concurrent Chemoradiotherapy ◽

Stage Iii ◽

Small Cell Lung ◽

Unresectable Stage

Download Full-text

The Influence of Pulmonary Diffusion Impairment on Prognosis of Unresectable Stage III Non-Small Cell Lung Cancer Patients Who Received Concurrent Chemoradiotherapy

10.1164/ajrccm-conference.2019.199.1_meetingabstracts.a5550 ◽

2019 ◽

Author(s):

T. Tozuka ◽

M. Seike ◽

H. Hayashi ◽

A. Miyanaga ◽

Y. Minegishi ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cancer Patients ◽

Cell Lung Cancer ◽

Concurrent Chemoradiotherapy ◽

Stage Iii ◽

Small Cell Lung ◽

Lung Cancer Patients ◽

Unresectable Stage

Download Full-text

Sequential chemoradiotherapy versus concurrent chemoradiotherapy plus consolidation chemotherapy in unresectable stage III non-small cell lung cancer

Journal of Clinical Oncology ◽

10.1200/jco.2008.26.15_suppl.18509 ◽

2008 ◽

Vol 26 (15_suppl) ◽

pp. 18509-18509

Author(s):

H. M. El-Shenshawy ◽

A. Fathy ◽

S. Eteba

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Concurrent Chemoradiotherapy ◽

Stage Iii ◽

Small Cell Lung ◽

Consolidation Chemotherapy ◽

Unresectable Stage

Download Full-text

Concurrent Chemoradiotherapy for Unresectable Stage III Non-Small Cell Lung Cancer

Clinical Cancer Research ◽

10.1158/1078-0432.ccr-05-9008 ◽

2005 ◽

Vol 11 (13) ◽

pp. 5045s-5050s ◽

Author(s):

E. E. Vokes

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Concurrent Chemoradiotherapy ◽

Stage Iii ◽

Small Cell Lung ◽

Unresectable Stage

Download Full-text

Consolidation chwemotherapy after concurrent chemoradiotherapy vs. chemoradiotherapy alone for locally advanced unresectable stage III non-small-cell lung cancer: A meta-analysis

Molecular and Clinical Oncology ◽

10.3892/mco.2016.910 ◽

2016 ◽

Vol 5 (2) ◽

pp. 271-278 ◽

Author(s):

Xiu-Jun Chang ◽

Zi-Tong Wang ◽

Lei Yang

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Concurrent Chemoradiotherapy ◽

Meta Analysis ◽

Locally Advanced ◽

Stage Iii ◽

Small Cell Lung ◽

Unresectable Stage

Download Full-text

121 Concurrent chemoradiotherapy for unresectable stage III non-small cell lung cancer: Experience of a single institution

Radiotherapy and Oncology ◽

10.1016/s0167-8140(04)80621-2 ◽

2004 ◽

Vol 72 ◽

pp. S37

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Concurrent Chemoradiotherapy ◽

Stage Iii ◽

Small Cell Lung ◽

Single Institution ◽

Unresectable Stage ◽

Cancer Experience

Download Full-text

Single-center comparison of multiple chemotherapy regimens for concurrent chemoradiotherapy in unresectable stage III non-small-cell lung cancer

Cancer Chemotherapy and Pharmacology ◽

10.1007/s00280-016-3226-0 ◽

2017 ◽

Vol 79 (2) ◽

pp. 381-387 ◽

Author(s):

Samer Tabchi ◽

Normand Blais ◽

Marie-Pierre Campeau ◽

Mustapha Tehfe

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Concurrent Chemoradiotherapy ◽

Stage Iii ◽

Single Center ◽

Small Cell Lung ◽

Unresectable Stage

Download Full-text

RATIONALE 001: Tislelizumab (BGB-A317) + concurrent chemoradiotherapy (cCRT) followed by tislelizumab monotherapy in patients (pts) with newly diagnosed locally advanced, unresectable, stage III non-small cell lung cancer (NSCLC)

Annals of Oncology ◽

10.1093/annonc/mdz063.083 ◽

2019 ◽

Vol 30 ◽

pp. ii67

Author(s):

L. Paz-Ares ◽

S. Senan ◽

D. Planchard ◽

L. Wang ◽

A. Cheong ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Concurrent Chemoradiotherapy ◽

Locally Advanced ◽

Stage Iii ◽

Newly Diagnosed ◽

Small Cell Lung ◽

Unresectable Stage

Download Full-text

M7824 With cCRT in Unresectable Stage III Non-small Cell Lung Cancer (NSCLC)

Case Medical Research ◽

10.31525/ct1-nct03840902 ◽

2000 ◽

Author(s):

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Stage Iii ◽

Small Cell Lung ◽

Unresectable Stage

Download Full-text